Cargando…
Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series
Aim: Coronavirus disease 2019 is a life-threatening disease and how to improve survival of the patients is of great importance. Objective: To determine whether tocilizumab (TCZ) shows favorable results in coronavirus disease 2019 patients. Materials & methods: A retrospective study of four patie...
Autores principales: | Cui, Ran, Zhu, Ying, Wang, Yulan, Chen, Xiao-Hua, Li, Qiang, Dai, Sheng-Ming, Tong, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151543/ https://www.ncbi.nlm.nih.gov/pubmed/34055031 http://dx.doi.org/10.2217/fvl-2020-0410 |
Ejemplares similares
-
Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series
por: Mady, Ahmed, et al.
Publicado: (2020) -
Tocilizumab for refractory morphea in adults: A case series
por: Lonowski, Sarah, et al.
Publicado: (2022) -
Role of Tocilizumab in the Treatment of COVID-19 Patients with Cytokine Storm: A Case Series
por: Basnet, Ajaya, et al.
Publicado: (2022) -
Pulmonary barotrauma in mechanically ventilated coronavirus disease 2019 patients: A case series
por: Edwards, Jodi-Ann, et al.
Publicado: (2020) -
Tocilizumab in the treatment of severe and refractory parenchymal
neuro-Behçet’s syndrome: case series and literature review
por: Liu, Jinjing, et al.
Publicado: (2020)